These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1345889)

  • 1. BRL 35135, a potent and selective atypical beta-adrenoceptor agonist.
    Cawthorne MA; Sennitt MV; Arch JR; Smith SA
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):252S-257S. PubMed ID: 1345889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents.
    Arch JR; Ainsworth AT; Ellis RD; Piercy V; Thody VE; Thurlby PL; Wilson C; Wilson S; Young P
    Int J Obes; 1984; 8 Suppl 1():1-11. PubMed ID: 6152555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.
    Santti E; Huupponen R; Rouru J; Hänninen V; Pesonen U; Jhanwar-Uniyal M; Koulu M
    Br J Pharmacol; 1994 Dec; 113(4):1231-6. PubMed ID: 7889277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermogenic and antiobesity activity of a novel beta-adrenoceptor agonist (BRL 26830A) in mice and rats.
    Arch JR; Ainsworth AT
    Am J Clin Nutr; 1983 Oct; 38(4):549-58. PubMed ID: 6137948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the beta3-adrenoceptor agonist BRL 35135 on UCP isoform mRNA expression.
    Emilsson V; Summers RJ; Hamilton S; Liu YL; Cawthorne MA
    Biochem Biophys Res Commun; 1998 Nov; 252(2):450-4. PubMed ID: 9826550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes.
    Cawthorne MA; Carroll MJ; Levy AL; Lister CA; Sennitt MV; Smith SA; Young P
    Int J Obes; 1984; 8 Suppl 1():93-102. PubMed ID: 6152558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute injection of beta-adrenoceptor agonist BRL 35135 corrects both impaired uncoupling protein and lipoprotein lipase gene expression but not hypercapacity of lipogenesis in brown adipose tissue of suckling fa/fa rats.
    Marie V; Dupuy F; Bazin R
    Int J Obes Relat Metab Disord; 1994 May; 18(5):273-9. PubMed ID: 7914794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the beta-adrenoceptor agonist BRL-35135 on development of obesity in suckling Zucker (fa/fa) rats.
    Charon C; Dupuy F; Marie V; Bazin R
    Am J Physiol; 1995 Jun; 268(6 Pt 1):E1039-45. PubMed ID: 7611376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of metabolic disorders and visceral fat obesity by the beta 3-adrenoceptor agonist (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2 -(3-chlorophenyl)ethylamino]propyl]-phenoxyacetate hydrobromide (BRL35135A) in genetically obese rodents.
    Hashimoto K; Nagao Y; Ida K; Takeda M; Murakami N; Kato K; Mizota M
    Biochem Pharmacol; 1996 Nov; 52(10):1529-35. PubMed ID: 8937467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation.
    Liu YL; Stock MJ
    Br J Pharmacol; 1995 Feb; 114(4):888-94. PubMed ID: 7773551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic administration of BRL 26830A for 9 weeks improves insulin sensitivity but does not prevent weight gain in gold-thioglucose obese mice.
    Bryson JM; Wensley VR; Phuyal JL; Caterson ID; Cooney GJ
    Horm Metab Res; 1999 May; 31(5):317-22. PubMed ID: 10422727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brown adipose tissue is a major site of glucose utilisation in C57Bl/6 ob/ob mice treated with a thermogenic beta-adrenoceptor agonist.
    Young P; Cawthorne MA; Smith SA
    Biochem Biophys Res Commun; 1985 Jul; 130(1):241-8. PubMed ID: 4026829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogenous activity of BRL 35135, a beta 3-adrenoceptor agonist, in thermogenesis and increased blood flow in brown adipose tissue in anaesthetized rats.
    Takahashi H; Nakamura S; Shirahase H; Yoshida T; Nishimura M; Yoshimura M
    Clin Exp Pharmacol Physiol; 1994 Jul; 21(7):539-43. PubMed ID: 7982286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate supply for thermogenesis induced by the beta-adrenoceptor agonist BRL 26830A.
    Wilson S; Thurlby PL; Arch JR
    Can J Physiol Pharmacol; 1987 Feb; 65(2):113-9. PubMed ID: 2882828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasts between the effects of zinc-α2-glycoprotein, a putative β3/2-adrenoceptor agonist and the β3/2-adrenoceptor agonist BRL35135 in C57Bl/6 (ob/ob) mice.
    Wargent ET; O'Dowd JF; Zaibi MS; Gao D; Bing C; Trayhurn P; Cawthorne MA; Arch JR; Stocker CJ
    J Endocrinol; 2013 Feb; 216(2):157-68. PubMed ID: 23151357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ZD7114, a selective beta3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance.
    Savontaus E; Pesonen U; Rouru J; Huupponen R; Koulu M
    Eur J Pharmacol; 1998 Apr; 347(2-3):265-74. PubMed ID: 9653893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of uncoupling proteins by chronic treatments with beta 3-adrenergic agonist BRL 35135 and metformin in obese fa/fa Zucker rats.
    Savontaus E; Rouru J; Boss O; Huupponen R; Koulu M
    Biochem Biophys Res Commun; 1998 May; 246(3):899-904. PubMed ID: 9618309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-obesity and anti-diabetic actions of a beta 3-adrenoceptor agonist, BRL 26830A, in yellow KK mice.
    Yoshida T; Hiraoka N; Yoshioka K; Hasegawa G; Kondo M
    Endocrinol Jpn; 1991 Aug; 38(4):397-403. PubMed ID: 1687027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brown adipose tissue cell respiration in hypo- and hyperthyroidism after stimulation with selective and non selective beta-adrenergic agonists.
    Ilyés I; Yahata T; Stock M
    Acta Biol Hung; 1991; 42(4):345-55. PubMed ID: 1688147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies with the beta-adrenoceptor agonist BRL 26830A.
    Connacher AA; Bennet WM; Jung RT
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):258S-261S. PubMed ID: 1345890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.